Epstein Secrets

to diagnose genetic diseases (i.e. cystic fibrosis, MLPA tests, D=NSR for NIPD of trisomy), and identify diseases using DNA microarrays a=d targeted Next-Gen sequencing. Earlier this year, I receiv=d the IFCC Award for Significant Contributions in Molecular Diagnostic=. I have been collaborating with Dr.

p multiplexed PCR-LDR assays for Category=A Biothreat agents, including all the major viral hemorrhagic fever viruses (VHF; ebolavirus, marburgvirus Crimean Congo=nbsp;hemorrhagic fever virus, Lassa fever virus, Rift Valley fever vir=s, Dengue virus, and Yellow fever virus). (Kindly see belo= abstract of manu

to diagnose genetic diseases (i.e. cystic fibrosis, MLPA tests, =ANSR for NIPD of trisomy), and identify diseases using DNA microarray= and targeted Next-Gen sequencing. Earlier this year, I re=eived the IFCC Award for Significant Contributions in Molecular Diagn=stics. I have been collaborating with Dr.

abling simultaneous identification of the pathogens. The assay wa= evaluated on 32 different isolates associated with VHF (ebolavirus,4>marburgvirus Crimean Congo hemorrhagic fever virus, Lassa fever =irus, Rift Valley fever virus, Dengue virus, and Yellow fever virus) as well as variola virus and vaccinia vir

o diagnose genetic diseases (i.e. cystic fibrosis, MLPA tests, C0=NSR for NIPD of trisomy), and identify diseases using DNA microarrays a=d targeted Next-Gen sequencing. Earlier this year, I receiv=d the IFCC Award for Significant Contributions in Molecular Diagnostic=. I have been collaborating with Dr.

ng simultaneous identification of the pathogens. The assay was=evaluated on 32 different isolates associated with VHF (ebolavirus,&nb=p;marburgvirus Crimean Congo hemorrhagic fever virus, Lassa fever viru=, Rift Valley fever virus, Dengue virus, and Yellow fever virus) as well as variola virus and vaccinia vir